Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT05438849

Improving Primary Care Access to Urinary Incontinence Treatment for Women Veterans

Conditions: Urinary Incontinence

Sex: Female
Ages: 20 Years – N/A
Healthy volunteers: No
Enrollment: 3214
Sponsor: University of Alabama at Birmingham

Location: Birmingham VA Healthcare System Birmingham Alabama

Summary

The PURSUIT project aims to improve access to evidence-based nonsurgical UI treatment for women Veterans in the Southeast region of the United States using the most effective remote delivery modality. Using cluster randomization, the study will compare two models at the practice level: (1) the use of a practice facilitation toolkit with a mHealth UI modality alone and (2) the practice facilitation toolkit with a mHealth UI model combined with education on clinical pathways for consultation. Patient level outcomes related to UI symptom improvement will be compared. Patient and provider perceptions of factors that could influence future remote UI treatment scalability will also be assessed. All primary care practices will receive practice facilitation with a PURSUIT toolkit that includes (1) 1-2 visits with a practice facilitator; (2) mobile-health or mHealth application training (MAT); 3) online resource hub; and (4) health information technology (HIT) assistance. PURSUIT's future goal is to disseminate the most effective modality for delivering nonsurgical UI treatment for women Veterans nationally within the VHA.

Eligibility Criteria

Inclusion Criteria: * Veteran * English-speaking, community-dwelling women Veterans * Diagnosis of UI (all types) * Access to the internet via a mobile device or computer Exclusion Criteria: * Women Veterans who are currently pregnant or less than 12 weeks postpartum

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05438849). StuddyBuddy aggregates publicly available trial information.